SterRx

SterRx was a U.S.-based sterile pharmaceutical manufacturer and FDA-registered 503B outsourcing facility focused on compounded sterile liquid drug products for hospital and health-system use. The company operated manufacturing and distribution facilities in Plattsburgh, New York and emphasized robotic automation, aseptic processing, and Blow-Fill-Seal technology to reduce human contact in production and packaging. Its business was services- and manufacturing-oriented rather than a traditional therapeutic R&D biotech pipeline, with capabilities spanning vial, syringe, infusion-bag, and BFS presentations. Public reporting indicates the company shut down its Plattsburgh operations in 2023 following regulatory and product-quality issues, including recalls and an FDA warning letter.